New treatment modalities for granuloma faciale.
Granuloma faciale (GF) is a rare, chronic skin disorder in which numerous treatment modalities have been used without any consistent long-term effect. We report three cases of GF, two of which were successfully treated with the Laserscope potassium-titanyl-phosphate 532-nm laser within 2 weeks and one with topical tacrolimus ointment 0.1%. Our observations suggest that these new treatment modalities for GF, which we report here for the first time, can provide effective and non-invasive treatment for this disease.
D000368:Aged; D003131:Combined Modality Therapy; D005148:Facial Dermatoses / Q000628:therapy*; D005260:Female; D006099:Granuloma / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*; D014025:Titanium / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D010710:Phosphates; C064806:potassium titanylphosphate; D014025:Titanium; D016559:Tacrolimus